American Diabetes Association. Executive summary: Standards of medical care in diabetes—2012. Diabetes Care, 2012; 35(Suppl 1):S4–S10.
2.
International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care, 2009; 32:1327–1334.
3.
Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation. World Health Organization website. www.who.int/diabetes/publications/diagnosis_diabetes2011/en/ Accessed January25, 2014.
4.
American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care, 2014; 37(Suppl 1):S14–S80.
5.
BennettCM, GuoM, DharmageSC. HbA(1c) as a screening tool for detection of type 2 diabetes: A systematic review. Diabet Med, 2007; 24:333–343.
6.
BhowmikB, DiepLM, MunirSB, et al.HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: The Bangladesh experience. Diabet Med, 2013; 30:e70–e77.
7.
LipskaKJ, De RekeneireN, Van NessPH, et al.Identifying dysglycemic states in older adults: Implications of the emerging use of hemoglobin A1c. J Clin Endocrinol Metab, 2010; 95:5289–5295.
8.
NairM, PrabhakaranD, NarayanKM, et al.HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians. Prim Care Diabetes, 2011; 5:95–102.
9.
ZhouX, PangZ, GaoW, et al.Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China. Diabetes Care, 2010; 33:545–550.
10.
CavagnolliG, ComerlatoJ, ComerlatoC, et al.HbA(1c) measurement for the diagnosis of diabetes: Is it enough?. Diabet Med, 2011; 28:31–35.
11.
GuoF, MoelleringDR, GarveyWT. Use of HbA1c for diagnoses of diabetes and prediabetes: Comparison with diagnoses based on fasting and 2-hr glucose values and effects of gender, race, and age. Metab Syndr Relat Disord, 2014 (PMID: 24512556)
12.
SacksDB, et al.The diagnosis of diabetes is changing: How implementation of hemoglobin A1c will impact clinical laboratories. Clin Chem, 2009; 55:1612–1614.
13.
OlsonDE, RheeMK, HerrickK, et al.Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care, 2010; 33:2184–2189.
14.
HigginsT. HbA(1c)—an analyte of increasing importance. Clin Biochem, 2012; 45:1038–1045.
15.
RheaJM, MolinaroR. Pathology consultation on HbA1c methods and interferences. Am J Clin Pathol, 2014; 141:5–16.
16.
InzucchiSE. Diagnosis of diabetes. N Engl J Med, 2013; 367:542–550.
17.
HaridkarPS, JoshiSM, BhatDS, et al.Spuriously high prevalence of prediabetes diagnosed by HbA(1c) in young indians partly explained by hematological factors and iron deficiency anemia. Diabetes Care, 2012; 35:797–802.
18.
LippiG, TargherG. A laboratory standpoint on the role of hemoglobin A1c for the diagnosis of diabetes in childhood: More doubts than certainties?. Pediatr Diabetes, 2011; 12(3 Pt 1):183–186.
19.
ZiemerDC, KolmP, WeintraubWS, et al.Glucose-independent, black-white differences in hemoglobin A1c levels: A cross-sectional analysis of 2 studies. Ann Intern Med, 2010; 152:770–777.
20.
WolffenbuttelBH, HermanWH, GrossJL, et al.Ethnic differences in glycemic markers in patients with type 2 diabetes. Diabetes Care, 2013; 36:2931–2936.
21.
GrimsbyJL, PornealaBC, VassyJL, et al.Race-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: The third National Health and Nutrition Examination Survey (NHANES III). BMC Med Genet, 2012; 13:30.
22.
MostafaSA, KhuntiK, SrinivasanBT, et al.The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort. Diabetes Res Clin Pract, 2010; 90:100–108.
23.
VenkataramanK, KaoSL, ThaiAC, et al.Ethnicity modifies the relation between fasting plasma glucose and HbA1c in Indians, Malays and Chinese. Diabet Med, 2012; 28:911–917.
24.
MohanV, VijayachandrikaV, GokulakrishnanK, et al.A1C cut points to define various glucose intolerance groups in Asian Indians. Diabetes Care, 2010; 33:515–519.
25.
McCarterRJ, HempeJM, GomezR, et al.Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care, 2004; 27:1259–1264.
26.
YudkinJS, ForrestRD, JacksonCA, et al.Unexplained variability of glycatedhaemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia, 1990:33:208–215.
27.
NayakAU, NevillAM, BassettP, et al.Association of glycation gap with mortality and vascular complications in diabetes. Diabetes Care, 2013; 36:3247–3253.
28.
SelvinE, SteffesMW, GreggE, et al.Performance of A1C for the classification and prediction of diabetes. Diabetes Care, 2011; 34:84–89.
29.
LuZX, WalkerKZ, O'DeaK, et al.A1C for screening and diagnosis of type 2 diabetes in routine clinical practice. Diabetes Care, 2010; 33:817–819.
30.
JialalI. Editor's perspective on metabolic syndrome for 2008. Metab Syndr Relat Disord, 2008; 6:85–86.
